Taisuke Kajino

1.1k citations
19 papers · 810 indexed · h-index 13
Topics
RNA modifications and cancer (8 papers)Cancer-related molecular mechanisms research (8 papers)MicroRNA in disease regulation (5 papers)
Partner nations
JapanUnited States

In The Last Decade

Taisuke Kajino

18 papers receiving 803 citations

Peers

Taisuke Kajino
Comparison fields: 5 of 74
  • Molecular Biology 530
  • Cancer Research 360
  • Immunology 225
  • Oncology 139
  • Pharmacology 58
Replace Lily Liu with:
Lily Liu United States
Nathalie Peters Germany
Jixiao Niu United States
Arifumi Iwamaru Japan
Susumu Rokudai Japan
Mohammad A. Noory United States
Qianqian Lei China
Shannon L. Wyszomierski United States
Suihai Wang China
Qiaofen Fu China
Taisuke Kajino relative to Lily Liu United States Lily Liu's profile →
Citations per field
00.5×6.7×
Lily Liu · 1×
Citations per year

Countries citing papers authored by Taisuke Kajino

Since Specialization
Citations

This map shows the geographic impact of Taisuke Kajino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taisuke Kajino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taisuke Kajino more than expected).

Fields of papers citing papers by Taisuke Kajino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taisuke Kajino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taisuke Kajino. The network helps show where Taisuke Kajino may publish in the future.

Co-authorship network of co-authors of Taisuke Kajino

This figure shows the co-authorship network connecting the top 25 collaborators of Taisuke Kajino. A scholar is included among the top collaborators of Taisuke Kajino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taisuke Kajino. Taisuke Kajino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 0
2 11
3 7
4 12
5 14
6 13
7 26
8 28
9 20
10 2
11 8
12 43
13 18
14 35
15 41
16 33
17 33
18 111
19 355

About Taisuke Kajino

Taisuke Kajino is a scholar working on Cancer Research, Toxicology and Molecular Biology, having authored 19 papers that have together received 810 indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (360 citations), Immunology (225 citations) and Molecular Biology (530 citations). Taisuke Kajino has collaborated with scholars based in Japan and United States. Frequent co-authors include Jun Ninomiya‐Tsuji, Kunihiro Matsumoto, Masashi Shiina, Toshihiko Ohtomo, Koichiro Ono, Masayuki Tsuchiya, Masahiko Mihara, Masahiko Matsumoto, Takashi Takahashi and Motoshi Suzuki. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026